Microbicides 2004 Microbicides 200428-31 March 2004, Hilton London MetropoleThe conference42 million men, women and children worldwide were living with HIV by the end of December 2002 (source: UNAIDS), including five million newly-infected during that year alone. Another 45 million people will become infected between 2002 and 2010, unless the current transmission rates can be vastly reduced. Of the 42 million, 29.4 million live in sub-Saharan Africa and 58% of them are women. Not only are women more susceptible to HIV infection, many are powerless to insist on the use of condoms or other methods of protecting themselves. In this context, and with the knowledge that an effective HIV vaccine is unlikely to be available for several years, the need for an effective topical microbicide grows ever more urgent. 2004 should prove to be a landmark year in the field of microbicide development as the first Phase III trials of novel products are due to start – the next step along the road to making a microbicide available to the millions worldwide in desperate need of protection.The aims of the Microbicides 2004 conference are to:Report novel or innovative work in the microbicides fieldProvide updates on recent microbicides research, divided into three tracks: basic science, clinical science, and behavioural science (including public health and the microbicide marketplace)Provide a forum for the discussion of new developments in microbicide research including ethical, clinical, behavioural and methodological issuesPresent opportunities for knowledge-sharing between microbicide researchers, public-health workers and advocacy organisations.There will be an opening ceremony on the evening of Sunday 28 March at which politicians, policy makers and the international media are expected. The conference will run for a full three days, each of which will contain:Scientific overviews and presentations with plenary sessions, invited lecturers and presentations of original researchWorkshops to review issues unique to microbicides such as trial design and outcome measures, and ethical issues in the clinical trials of microbicidesPoster sessions. Focus on LondonFollowing the successful Microbicides conferences in Washington in 2000 and Antwerp in 2002, March 2004 sees the focus move to London.The venue is the Hilton Metropole Hotel, two minutes by taxi from Paddington station and the Heathrow Express, with a journey time from the airport of 15 minutes. The hotel is in walking distance of Hyde Park and London’s main shopping streets, and close to Imperial College. Accommodation will be available at the venue and other hotels in the vicinity.London in March offers a variety of diversions for out-of-conference relaxation, including sight-seeing and shopping; the arts and the theatre; and pubs, clubs and restaurants to suit every taste. Conference staff will be on hand to help delegates plan their spare time.To book your place or find out more information, e-mail info@microbicides2004.org.uk or telephone the Event Office on +44 (0) 20 7720 4411
Oral: invited speaker Oral: Track A Oral: Track B Oral: Track C Poster: Track A Poster: Track B Poster: Track C Abstract only Authors

Poster presentations: Track C

02014 ACCEPTABLITY OF DEXTRIN SULPHATE GEL IN WOMEN PARTICIPATING IN A PHASE II TRIAL IN KAMPALA, UGANDA

02023 KNOWLEDGE, PERCEPTION & ACCEPTABILITY OF MICROBICIDES AMONG HEALTH CAREGIVERS IN LAGOS STATE NIGERIA

02053 ASSESSMENT OF SEXUAL BEHAVIOUR AND CONDOM USE AMONG FEMALE ADOLESCENTS IN awassa, ETHIOPIA

02118 GENESIS OF MICROBICIDES CAMPAIGN IN INDIA

02131 ANITICIPATED ACCEPTABILITY OF A VAGINAL MICROBICIDE AMONG MEN ATTENDING THE MULAGO STD CLINIC IN KAMPALA, UGANDA

02149 RESEARCH COMMUNITY AND THEIR NEEDS. HOW CAN WE HELP?

02150 A PRELIMINARY COMPARATIVE STUDY ON CONDOM SOCIAL MARKETING VERSUS THE PROSPECT OF INTRODUCING MICROBICIDES AS AN ALTERNATIVE FOR HIV PREVENTION IN KATSINA STATE, NIGERIAPREVENTION

02170 ATTITUDES TOWARDS, AND EXPECTATIONS FOR, VAGINAL MICROBICIDES AMONG THAI HIV PREVENTION POLICYMAKERS

02198 ACCEPTABILITY OF FEMALE CONDOM AND VAGINAL MICROBICIDE USE AMONG AT RISK FEMALES IN THE GAMBIA

02216 KNOWLEDGE, ATTITUDE AND PERCEPTIONS OF NIGERIAN CHURCHES AND FAITH ORGANIZATIONS TOWARDS MICROBICIDES

02219 INVOLVEMENT OF MEDIA EXECTIVES/PRACTITIONERS AS MEMBERS OF CONTRACEPTIVE SOCIAL INFORMATIONSYSTEM TOWARDS MICROBICIDES: THE NIGERIA INITIATIVE.

02224 AWARENESS AND POTENTIAL FOR USE OF NEW HIV PREVENTION TECHNOLOGIES AMONG GAY MEN IN THE UK

02255 INSTITUTIONAL CAPACITY AS A LIMITING FACTOR FOR MICROBICIDE RESEARCH IN NIGERIA

02262 ADVOCACY AND POLICY DEVELOPMENT TOOLS CAN ENHANCE MICROBICIDE CAMPAIGN

02269 MICROBICIDE ACCEPTABILITY AMONG HIGH-RISK URBAN U.S. WOMEN: EXPERIENCES AND PERCEPTIONS OF SEXUALLY

02311_1 ACCEPTABILITY OF MICROBICIDES AMONG MALE PARTNERS OF THE COL 1492 TRIAL PARTICIPANTS

02320 USE OF A SIMULATED MICROBICIDE IN TWO-WEEK TRIALS BY HIGH-RISK WOMEN IN HARTFORD, CONNECTICUT

02355 MICROBICIDES DEVELOPMENT PROCESS IS A CHALLENGE: INDIA EXPERIENCE

02377 MICROBICIDE TRIAL FEASIBILITY STUDY IN HIGH-RISK WOMEN IN MWANZA, TANZANIA: LESSONS LEARNED

02379 EVALUATION OF KNOWLEDGE AND ACCEPTABILITY OF MICROBICIDES BY COMMERCIAL SEX WORKERS IN LAGOS NIGERIA

02384 THE ASSESMENT OF DIFFERENT METHODS OF COLLECTING SEXUAL INFORMATION DATA ON CONDOM USE

02385 DRY SEX PRACTICE IN A ZAMBIAN COMMUNITY

02388 SEXUAL BEHAVIOUR AND ATTITUDES TOWARDS VAGINAL MICROBICIDES AMONG COUPLES IN RURAL SW UGANDA

02389 COUPLE HIV COUNSELLING AND TESTING IN FEASIBILITY STUDY FOR A PHASE III MICROBICIDE TRIAL IN UGANDA

02390_2 IMPLICATIONS OF CURRENT INTRAVAGINAL PRACTICES AMONG FEMALE SEX WORKERS IN NAIROBI, KENYA

02391_1 SEXUAL BARRIER PRODUCT ACCEPTABILITY PREDICTS USE AMOUNG HIV- POSITIVE ZAMBIAN WOMEN

02391_2 SEXUAL BARRIER PRODUCT ACCEPTABILITY PREDICTS USE AMOUNG HIV- POSITIVE U.S. WOMEN

02413 PREFERENCE FOR GEL USE WITH DIAPHRAGMS IN ZIMBABWE

02418 BUILDING COMMUNITY MOBILISATION FOR MICROBICIDES - THE TIME IS NOW

02422 ACCEPTABILITY OF VAGINAL MICROBICIDES IN PUNE, INDIA: DEVELOPMENT AND VALIDATION OF MEASURES

02441 SEXUAL PRACTICES OF WOMEN RECRUITED TO A MICROBICIDE TRIAL FEASIBILITY STUDY IN MWANZA, TANZANIA 

02448 MICROBICIDES INTRODUCTION IN TAMIL NADU, INDIA: POLICY MAKERS’ PERSPECTIVES

02449 PHASE III MICROBICIDE TRIALS: CONFRONTING THE SCIENTIFIC, REGULATORY AND ETHICAL CHALLENGES

02468 ROLE OF COMMUNITY BASED ORGANIZATIONS IN ADVOCACY AND MOBILIZATION AROUND MICROBICIDES

02474 ASSESSING MEN’S KNOWLEDGE AND ATTITUDE TOWARDS MICROBICIDES

02475 CHALLENGES IN ACCESS AND USE OF MICROBICIDES

02476 ASSESSING THE NEED FOR A NON CONTRACEPTIVE VAGINAL MICROBICIDE

02500 HIV PREVENTATIVE STRATEGIES AND THE USER OF ANTI RETROVIRAL DRUGS

02527 SELF-REPORTED CONDOM USE AND HIV/STD INCIDENT CASES: HIV PREVENTION TRIALS NETWORK STUDY 016A

02530 MICROBICIDES ADVOCACY: CHALLENGE OF RURAL WOMEN

02571 READINESS OF A RESEARCH SITE TO DELIVER ON A PHASE III MICROBICIDE TRIAL IN DURBAN, SOUTH AFRICA.

02580_1 MALE PARTNERS ACCEPTABILITY OF PMPA GEL AS VAGINAL MICROBICIDE: HPTN 050

02580_2 INTENTIONS TO USE RECTAL MICROBICIDES AND PRIOR USE OF ANAL LUBRICANTS WITH NONOXYNOL-9 IN A PROBABILITY SAMPLE OF MEN WHO HAVE SEX WITH MEN

02583 HPTN 050

02585 THE ACCEPTABILITY OF A NOVEL VAGINAL MICROBICIDE, CELLULOSE SULFATE GEL, AMONG HIV-POSITIVE FEMALES: HPTN 049

02587 PROJECT ON PROMOTION AND AWARENESS ABOUT MICROBICIDES

02589 SWAA: USING FEMALE CONDOM TO PAVE THE WAY FOR MICROBICIDES AT AFRICA’S GRASSROOTS

02592 EUROPEAN ADVOCACY EFFORTS: WHY DO THEY MATTER?

02599 PREFERENCES FOR A HERPES-PREVENTION MICROBICIDE AMONG WOMEN IN CALIFORNIA

02602 A NEW LOOK AT AN OLD METHOD: EXPLORING DIAPHAGM USE AMONG WOMEN IN TWO U.S. SAMPLES

02621 USING Q METHODOLOGY TO ASSESS OPINIONS OF STAKEHOLDERS ABOUT USE OF CERVICAL BARRIERS IN LOW-RESOURCE SETTINGS

02622 MARKETED VAGINAL PRODUCTS AS MICROBICIDES: A STRATEGY FOR INDIA

02623 CLEANING EFFECTIVENESS STUDY OF A MICROBICIDE APPLICATOR

02628_1 THE BESTBET STUDY: A “BODY EMPOWERMENT” INTERVENTION TO HELP WOMEN USE VAGINAL HIV PROTECTION

02628_2 WOMEN’S RIGHT TO MICROBICIDES: CONDITIONAL OR UNCONDITIONAL?

02632 STAINING STUDIES WITH SULFONATED HESPERIDIN (SH), A NOVEL MICROBICIDE

02635-1 THE PREVALENCE OF ANAL SEX IN RURAL SOUTH AFRICA

02635_2 COMMUNITY ATTITUDES TOWARDS INDIVIDUALS INFECTED WITH HIV IN RURAL KWA-ZULU NATAL

02637 NOTHING NEW?: A QUALITATIVE INVESTIGATION OF GAY MEN’S UNDERSTANDINGS OF MICROBICIDES

02642 ROLE OF MEN IN STUDIES INVOLVING FEMALE CONTROLLED PREVENTIVE STRATEGIES

02644 MOBILISING COMMUNITY INVOLVEMENT IN RANDOMISED MICROBICIDE CLINICAL TRIALS: LESSONS FROM 6 MDP SITES

02648 HIV/AIDS EPIDEMIC SITUATION AND DEVELOPING OF MICROBICIDES IN CHINA

02649 MOBILISING MEDIA ADVOCACY AND COMMUNITY PREPAREDNESS FOR FEMALE CONTROLLED OPTIONS IN NIGERIA

02650 MICROBICIDES AND THE GROUND REALITY-A SITUATIONAL ANALYSIS INVISAKHAPATNAM OF ANDHRAPRADESH, IN 

02654 MALE INVOLVEMENT IN MICROBICIDES: INSIGHTS FROM SOUTH AFRICA

02660 PREPARING FOR MICROBICIDE INTRODUCTION: FINDINGS FROM SOUTH AFRICA

02667 AN ASSESSMENT OF SEXUAL PRACTICES AFFECTING THE FEASABILITY OF MICROBICIDE DEVELOPMENT AMONG MSM

02669_1 RESULTS FROM A MICROBICIDE FEASIBILITY STUDY IN FAMILY PLANNING CLIENTS IN SOWETO, SOUTH AFRICA.

02670 LAUNCHING MICROBICIDES, HOW IMPORTANT IS PROMOTION? LESSONS FROM CONDOM SOCIAL MARKETING

02672 COMBINATION PREVENTION: CONSIDERING THE IMPACT OF NEW PREVENTION TECHNOLOGIES ON HIV PREVENTION

02673 COITAL DIARIES TO MEASURE FREQUENCY OF SEXUAL PRACTICES IN MWANZA, TANZANIA

02677 HIGH LEVELS OF COMPREHENSION AND WILLINGNESS TO PARTICIPATE AMONG WOMEN AND MEN IN BOTSWANA 

02678 BELIEFS ABOUT HIV/AIDS TRANSMISSION AND PERCEIVED RISK AMONG WOMEN AND MEN IN BOTSWANA

02680 MARKET POTENTIAL FOR A TOPICAL PREVENTION METHOD FOR RECURRENT UTI AND BV

02684 THE EFFECT OF INTRODUCING THE DIAPHRAGM ON MALE CONDOM USE

02692 PARTNER INVOLVEMENT IN A PHASE III CARRAGAURD TRIAL® (POPULATION COUNCIL)

02693 COMMUNITY PARTICIPATION IN A GA-RANKUWA/ SOSHANGUVE PHASE III CARRAGAURD TRIAL® (POPULATION COUNCIL)

02695 WHO USES CONDOMS? EVIDENCE FROM POPULATION SURVEYS IN SUB-SAHARAN AFRICA AND ASIA

02754 ANAL SEX AND CONDOM USE AMONGST PARTICIPANTS IN A MICROBICIDE FEASIBILITY STUDY 

02755 BUILDING MULTISTAKE HOLDER CONSTITUANCIES TO SUPPORT MICROBICIDES DEVELOPMENT AND PROMOTION

03115 MICROBICIDES: THE IMPACT OF RAPE IN MEETING DIVERSE NEEDS

03119 SITUATIONAL ANALYSIS OF HIV RELATED STANDARD OF CARE AVAILABLE AMONG TARGETED RESEARCH COMMUNITIES